Company / Free Cash Flow per Share
ENANTA PHARMACEUTICALS INC Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$5.29
FY2025
5-year range
-$5.29 / $3.29
FY2021-FY2025
Trend
-28.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has declined for 4 consecutive years, from $3.29 in FY2021 to $-5.29 in FY2025.
Based on SEC 10-K filings.
-5.29 in FY2025.
Declined from $-3.40 to $-5.29 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENANTA PHARMACEUTICALS INC's free cash flow per share has declined for 4 consecutive years.
- In FY2025, free cash flow per share decreased 28.3% year-over-year.
- Peak free cash flow per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.29 | -28.3% |
| FY2024 | -$4.13 | -21.3% |
| FY2023 | -$3.40 | -1320.3% |
| FY2022 | $0.28 | -91.5% |
| FY2021 | $3.29 | +146.9% |
| FY2020 | $1.33 | -48.5% |
| FY2019 | $2.59 | +59.1% |
| FY2018 | $1.63 | -58.4% |
| FY2017 | $3.91 | +281.7% |
| FY2016 | $1.02 | +89.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026